BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 34346744)

  • 1. SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.
    Sun F; Wang X; Tan S; Dan Y; Lu Y; Zhang J; Xu J; Tan Z; Xiang X; Zhou Y; He W; Wan X; Zhang W; Chen Y; Tan W; Deng G
    Microbiol Spectr; 2021 Sep; 9(1):e0026121. PubMed ID: 34346744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.
    Rocheleau L; Laroche G; Fu K; Stewart CM; Mohamud AO; Côté M; Giguère PM; Langlois MA; Pelchat M
    mBio; 2021 Jun; 12(3):e0078821. PubMed ID: 34182784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia.
    Armero A; Berthet N; Avarre JC
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis.
    Gao R; Zu W; Liu Y; Li J; Li Z; Wen Y; Wang H; Yuan J; Cheng L; Zhang S; Zhang Y; Zhang S; Liu W; Lan X; Liu L; Li F; Zhang Z
    Virulence; 2021 Dec; 12(1):1209-1226. PubMed ID: 34030593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.
    Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H
    Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quasispecies Analysis of SARS-CoV-2 of 15 Different Lineages during the First Year of the Pandemic Prompts Scratching under the Surface of Consensus Genome Sequences.
    Bader W; Delerce J; Aherfi S; La Scola B; Colson P
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
    Ruiz-Rodriguez P; Francés-Gómez C; Chiner-Oms Á; López MG; Jiménez-Serrano S; Cancino-Muñoz I; Ruiz-Hueso P; Torres-Puente M; Bracho MA; D'Auria G; Martinez-Priego L; Guerreiro M; Montero-Alonso M; Gómez MD; Piñana JL; ; González-Candelas F; Comas I; Marina A; Geller R; Coscolla M
    mBio; 2021 Dec; 12(6):e0231521. PubMed ID: 34781748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates.
    Schrörs B; Riesgo-Ferreiro P; Sorn P; Gudimella R; Bukur T; Rösler T; Löwer M; Sahin U
    PLoS One; 2021; 16(9):e0249254. PubMed ID: 34570776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-dependent editing of SARS-CoV-2 in COVID-19 patients.
    Gregori J; Cortese MF; Piñana M; Campos C; Garcia-Cehic D; Andrés C; Abril JF; Codina MG; Rando A; Esperalba J; Sulleiro E; Joseph J; Saubí N; Colomer-Castell S; Martin MC; Castillo C; Esteban JI; Pumarola T; Rodriguez-Frias F; Antón A; Quer J
    Emerg Microbes Infect; 2021 Dec; 10(1):1777-1789. PubMed ID: 34402744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of SARS-CoV-2 isolated from COVID-19 family clusters.
    Gunadi ; Wibawa H; Hakim MS; Marcellus ; Trisnawati I; Khair RE; Triasih R; Irene ; Afiahayati ; Iskandar K; Siswanto ; Anggorowati N; Daniwijaya EW; Supriyati E; Nugrahaningsih DAA; Budiono E; Retnowulan H; Puspadewi Y; Puspitawati I; Sianipar O; Afandy D; Simanjaya S; Widitjiarso W; Puspitarani DA; Fahri F; Riawan U; Fauzi AR; Kalim AS; Ananda NR; Setyati A; Setyowireni D; Laksanawati IS; Arguni E; Nuryastuti T; Wibawa T;
    BMC Med Genomics; 2021 Jun; 14(1):144. PubMed ID: 34074255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan.
    Umair M; Ikram A; Salman M; Khurshid A; Alam M; Badar N; Suleman R; Tahir F; Sharif S; Montgomery J; Whitmer S; Klena J
    PLoS One; 2021; 16(3):e0248371. PubMed ID: 33755704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients.
    Andrés C; Garcia-Cehic D; Gregori J; Piñana M; Rodriguez-Frias F; Guerrero-Murillo M; Esperalba J; Rando A; Goterris L; Codina MG; Quer S; Martín MC; Campins M; Ferrer R; Almirante B; Esteban JI; Pumarola T; Antón A; Quer J
    Emerg Microbes Infect; 2020 Dec; 9(1):1900-1911. PubMed ID: 32752979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions.
    Soliman MS; AbdelFattah M; Aman SMN; Ibrahim LM; Aziz RK
    OMICS; 2021 Feb; 25(2):123-128. PubMed ID: 33253058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins.
    Sahin E; Bozdayi G; Yigit S; Muftah H; Dizbay M; Tunccan OG; Fidan I; Caglar K
    J Med Virol; 2021 Oct; 93(10):6016-6026. PubMed ID: 34241906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal.
    Borges V; Isidro J; Cortes-Martins H; Duarte S; Vieira L; Leite R; Gordo I; Caetano CP; Nunes B; Sá R; Oliveira A; Guiomar R; ; Gomes JP
    Emerg Microbes Infect; 2020 Dec; 9(1):2488-2496. PubMed ID: 33131453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
    Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain.
    Ip JD; Kok KH; Chan WM; Chu AW; Wu WL; Yip CC; To WK; Tsang OT; Leung WS; Chik TS; Chan KH; Hung IF; Yuen KY; To KK
    Clin Microbiol Infect; 2021 Sep; 27(9):1350.e1-1350.e5. PubMed ID: 33144203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 genomic and quasispecies analyses in cancer patients reveal relaxed intrahost virus evolution.
    Siqueira JD; Goes LR; Alves BM; de Carvalho PS; Cicala C; Arthos J; Viola JPB; de Melo AC; Soares MA
    bioRxiv; 2020 Aug; ():. PubMed ID: 32869023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.